Clinical Trial Update: Oral Vancomycin for Preventing Clostridium Difficile Recurrence [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral vancomycin for preventing recurrence of Clostridium difficile infection; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Rochester General Hospital | Conditions: Clostridium Difficile Infection | Phase 4 | Status: TERMINATED